OTC Pet Medication Market
OTC Pet Medication market study with market size, share, valuation, segment-wise analysis, competitive landscape analysis, regulatory framework analysis and impact of Covid-19 Outbreak on OTC Pet Medication industry.
Global Market Study on OTC Pet Medication: Increasing Pet Humanization Trend Giving Impetus to Market Growth
- Report code : PMRREP31512 |
- Industry : Consumer Goods |
- Published On : May-2020 |
- Pages : 300 Pages |
- Format :
Pet ownership has been increasing across the world, primarily driven by changes in lifestyle, increase in disposable income, and more people wanting pets as companions. These factors, in turn, increase in subsequent or parallel industries such OTC pet medication. Increasing pet ownership and awareness related to pet diseases or pet health have fuelled the demand for OTC pet medication. In the OTC pet medication market, companies are offering pet medicines at competitive prices through various sales channels such as drug & pharmacy stores, pet specialty stores, etc. OTC pet medications are also available through online platforms, which has become a lucrative sales channel for the OTC pet medication market.
Rising Demand for Flea & Tick and Pain Relief & Arthritis Products
Flea allergy dermatitis and lyme disease are common types of diseases carried and transmitted by fleas & ticks. The second-most common health issue found among pets is arthritis. The OTC pet medication market is primarily driven by flea & tick and pain relief & arthritis products. These products, combined, hold 70% of the total OTC pet medication market share. Increasing usage of flea & tick and pain relief & arthritis products is majorly driven by the potential risk of transmission to humans.
COVID-19 Impact on OTC Pet Medication Market
Social distancing and lockdowns across in most countries have interrupted the production and supply of goods and raw materials in the OTC pet medication market space. Most retail operations have been shut down temporarily, which is lowering the sales of OTC pet medication products. This has resulted in lower OTC pet medication sales volume in the first quarter of 2020. The market is expected to recover in 2021, with East & South Asia are projected to witness higher growth rates as compared to other markets.
OTC Pet Medication Market: Competition Analysis
The global OTC pet medication market is fairly consolidated in nature, where, a majority of players focus on product formulation & development, regular product launches, and mergers & acquisitions.
- Collaborations and acquisition of niche players is a key strategy being followed by leading OTC pet medication manufacturers.
- In 2018, Zoetis Inc. expanded its animal vaccines research and manufacturing in Suzhou, China. The company is focusing on the development and manufacturing of vaccines and supplements for companion animals, fish, cattle, and pigs. It is also planning to expand its physical presence by establishing new manufacturing and distribution centers in east China.
- Several OTC pet medication companies are significantly spending more on promotional activities, expanding their physical store presence, and entering into strategic partnerships with prominent partners such as Walmart and 1800petmed for increasing their share in the OTC pet medication landscape.
Regional Overview of Global OTC Pet Medication Market
The OTC pet medication market is estimated to be valued at US$ 8.3 Bn in 2020. According to PMR’s report, the market is estimated to register a CAGR of over 4% during the forecast period of 2020-2030. North America remains the largest shareholder in the global OTC pet medication market, followed by Europe. The U.S. has emerged as a dominant country in OTC pet medication in terms of consumption. East Asia, South Asia, and Latin America will offer substantial growth opportunities for the OTC pet medication market.
Analysts’ Viewpoint
A brief overview of the changing landscape of the OTC pet medication market has led our analysts to conclude that, the market is gaining momentum. Key manufacturers in the OTC pet medication market, such as Boehringer Ingelheim Animal Health, Bayer Companion Animal, and Merck & Co., Inc., are prioritizing innovation and new product development to gain a competitive edge in the market. Most companies are currently focusing on new innovation through new formulation development and new product launches such as natural OTC medication for pets. Apart from developed countries, companies can focus on emerging markets such as China, India, Brazil, etc.
OTC Pet Medication Market - Scope of the Report
Persistence Market Research (PMR) recently published a new report on the OTC pet medication market for the assessment period of 2020-2030. The report offers a close look at the evolving aspects of the OTC pet medication market, and insights into the dynamics impacting market growth. It also focuses on key developments in the OTC pet medication market. The report includes various macro- and micro-economic factors responsible for having a significant impact on the OTC pet medication market.
The report on the OTC pet medication market extensively focuses on the key trends shaping its growth. Additionally, the included opportunity analysis on OTC pet medication underlines untapped corners for aspiring players. The report on the OTC pet medication market also offers a holistic view of the incremental opportunity, which can further help readers make effective decisions for the growth of their businesses.
All the stakeholders in the OTC pet medication market can rely on the data offered in this report to make critical decisions. Moreover, the information offered in this report also can help new market entrants expand their bases in the OTC pet medication market.
The report elaborates on both, historical and current trends shaping the market. The performance journey of the OTC pet medication market been drawn and analyzed to make lucrative opportunities in the market evident to readers. The competitive landscape presented in the OTC pet medication market report gives a detailed outlook of the profiles of key companies operating in the market, along with their differential strategies and key focus areas.
OTC Pet Medication Market: Segmentation
PMR’s research study on the global OTC pet medication market offers a detailed market taxonomy, wherein, key segments have been discussed in detail. The OTC pet medication market is segmented on the basis of application, pet, form, sales channel, and region. Every segment is analyzed in detail, and data pertaining to the growth of each segment has been included in the study.
|
Application |
|
|
Pet |
|
|
Form |
|
|
Sales Channel |
|
|
Region |
|
The OTC pet medication market research report includes a competitive landscape that provides a dashboard view of the key competitors operating in the market. Some of the market players included in this section are Boehringer Ingelheim Animal Health, Ceva Sante Animale, Bayer Companion Animal, Merck Inc., Zoetis Inc., Elanco, Virbac SA, Vetoquinol SA, Frontline, Elanco, and others.
OTC Pet Medication Market: Key Questions Answered in the Report
The research study on the OTC pet medication market offers inclusive insights about the growth of the market in the most comprehensive manner. Key insights offered in the OTC pet medication market report answer some of the most salient questions that assist stakeholders in gauging all the emerging possibilities.
- How is the rapidly changing business environment impacting the growth of the OTC pet medication market?
- What are the key trends that are constantly shaping the growth of the OTC pet medication market?
- Which are the prominent regions that offer plentiful opportunities for players in the OTC pet medication market?
- What are the differential strategies adopted by key players to hold a significant share in the global OTC pet medication market?
OTC Pet Medication Market: Research Methodology
A unique and promising research methodology forms the base of the OTC pet medication market report for the forecast period. This report has been prepared after a comprehensive analysis of market events, and riveting insights have been compiled meticulously. The research methodology for the OTC pet medication market report is a two-step process, comprising primary and secondary research. Key stakeholders such as suppliers, service providers, and experts of several designations, including executive vice presidents, directors, technical advisors, GM marketing professionals, and sales professionals have been interviewed. Secondary sources referred to obtain information include investor presentations of manufacturers, World Bank, IMF, and other credible sources.
Companies covered in Otc Pet Medication Market Report
- Bayer Companion Animal
- Boehringer Ingelheim Animal Health
- Ceva Sante Animale
- Merck Inc.
- Zoetis Inc.
- Elanco
- Virbac SA
- Vetoquinol SA
- Frontline
- Zymox
- ChloraSeb
- Sulfox
- Adequan
- Dechra Pharmaceuticals PLC
- Nutramax Laboratories, Inc.
- Others (On Request)
